2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

In Stock•Starting at $133 for 25 mg•Purity ≥ 98%

CAS No.	2170729-29-8
MDL No.	MFCD32263046
MF	C₁₇H₁₀F₃N₃O₃S₂
MW	425.40
InChI Key	ORQGHAJIWGGFJK-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability
25 mg	98%	$133	In Stock
50 mg	98%	$224	In Stock
100 mg	98%	$379	In Stock
250 mg	98%	$755	In Stock

Product Information

CAS No.	2170729-29-8
Product Name	2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Associated Conditions

galactosemia·classic galactosemia·peripheral neuropathy

* The information provided here is compiled from public sources and is for reference only.

2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

In Stock•Starting at $133 for 25 mg•Purity ≥ 98%

CAS No.	2170729-29-8
MDL No.	MFCD32263046
MF	C₁₇H₁₀F₃N₃O₃S₂
MW	425.40
InChI Key	ORQGHAJIWGGFJK-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability
25 mg	98%	$133	In Stock
50 mg	98%	$224	In Stock
100 mg	98%	$379	In Stock
250 mg	98%	$755	In Stock

Product Information

CAS No.	2170729-29-8
Product Name	2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Associated Conditions

galactosemia·classic galactosemia·peripheral neuropathy

* The information provided here is compiled from public sources and is for reference only.

2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency.

Rare disease therapeutics: The future of medical genetics in a changing landscape.

Documentation

Similar Products

Caficrestat

2-(4-Oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)thieno(3,4-d)pyridazin-1-yl)acetic acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency.

Rare disease therapeutics: The future of medical genetics in a changing landscape.

Documentation

Similar Products

Caficrestat